Device Trial Radar · NCT05378347
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Last checked: Nov 19, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Jan 5, 2023
Primary completion
May 2027
Study completion May 2031
Sponsor
- Lead sponsor
- Medtronic CardiovascularPublic (MDT)
- Sponsor type
- Industry
- First posted
- May 18, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.
Conditions
- Abdominal Aortic Aneurysm
- Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
- Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Interventions
Medtronic Endurant II or Endurant IIs Stent Graft SystemDevice
EVAR treatment with Medtronic Endurant II/IIs Stent Graft System
Gore Excluder or Gore/ Excluder Conformable AAA EndoprosthesisDevice
EVAR treatment with Excluder / Excluder Conformable Stent Graft System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sac RegressionTime frame: 12 months
Locations
68 sites in 12 countries. Site status is shown where the registry gives one.
Loma Linda University Medical Center
Loma Linda, California · Recruiting
Hoag Hospital
Newport Beach, California · Recruiting
University of California Irvine Medical Center
Orange, California · Recruiting
65 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.